SCHEMBL25482034

SCHEMBL25482034

COCCCn1c(SCC(=O)Nc2ccc(OC)cc2)nc2ccccc2c1=O

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.82
▸ USP2 O75604 2/20 0.82
▸ NPSR1 Q6W5P4 1/20 0.82
▸ NPC1 O15118 1/20 0.82
▸ MAPT P10636 1/20 0.82
▸ RAB9A P51151 1/20 0.82
▸ GUSB P08236 1/20 0.77
▸ KMT2A Q03164 4/20 0.76
▸ GAA P10253 1/20 0.76
▸ MAPK1 P28482 1/20 0.76
▸ MEN1 O00255 3/20 0.73
▸ LMNA P02545 2/20 0.72
▸ RXFP1 Q9HBX9 1/20 0.71
▸ CYP1A2 P05177 1/20 0.71
▸ CYP3A4 P08684 1/20 0.71
▸ CYP2D6 P10635 1/20 0.71
▸ CYP2C9 P11712 1/20 0.71
▸ TSHR P16473 1/20 0.71
▸ CYP2C19 P33261 1/20 0.71
▸ CA2 P00918 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25481989 0.92 ALDH1A1 (0.78) ALDH1A1USP2NPSR1NPC1MAPT
SCHEMBL25482008 0.92 L3MBTL1 (0.78) ALDH1A1USP2NPSR1NPC1MAPT
SCHEMBL25482037 0.86 ALDH1A1 (0.74) ALDH1A1USP2NPSR1NPC1MAPT
SCHEMBL25482090 0.86 ALDH1A1 (0.74) ALDH1A1USP2NPSR1NPC1MAPT
SCHEMBL16844168 0.79 KMT2A (0.73) ALDH1A1USP2NPSR1NPC1MAPT
SCHEMBL2723919 0.78 TP53 (0.73) ALDH1A1USP2NPSR1NPC1MAPT
SCHEMBL25482072 0.76 KMT2A (0.78) ALDH1A1NPSR1MAPTKMT2AMAPK1
SCHEMBL2722509 0.76 KMT2A (0.84) ALDH1A1NPSR1MAPTGUSBKMT2A
SCHEMBL25482005 0.75 TDP1 (0.70) ALDH1A1USP2NPSR1MAPTKMT2A
SCHEMBL25482016 0.74 LMNA (0.82) ALDH1A1NPSR1NPC1GUSBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230158028-A1 COMPOUNDS AND METHODS FOR INDUCING UCP1 EXPRESSION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2023-05-25 — — US disclosed
US-20230158028-A1 COMPOUNDS AND METHODS FOR INDUCING UCP1 EXPRESSION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2023-05-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230158028-A1 COMPOUNDS AND METHODS FOR INDUCING UCP1 EXPRESSION TFAM, FABP4, CPT2 ALDH1A1 1604/4885USP2 2293/4885NPSR1 3572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback